Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Noble Romans (NROM) EBITDA (2016 - 2025)

Historic EBITDA for Noble Romans (NROM) over the last 15 years, with Q3 2025 value amounting to $819065.0.

  • Noble Romans' EBITDA rose 9659.62% to $819065.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 954.15%. This contributed to the annual value of $1.5 million for FY2024, which is 5711.71% down from last year.
  • Latest data reveals that Noble Romans reported EBITDA of $819065.0 as of Q3 2025, which was up 9659.62% from $913999.0 recorded in Q2 2025.
  • Noble Romans' EBITDA's 5-year high stood at $1.5 million during Q1 2023, with a 5-year trough of -$394871.0 in Q4 2022.
  • For the 5-year period, Noble Romans' EBITDA averaged around $496159.7, with its median value being $432203.0 (2024).
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 37241981.13% in 2022, then soared by 85873.43% in 2023.
  • Quarter analysis of 5 years shows Noble Romans' EBITDA stood at -$106.0 in 2021, then crashed by 372419.81% to -$394871.0 in 2022, then skyrocketed by 276.17% to $695629.0 in 2023, then tumbled by 90.18% to $68282.0 in 2024, then soared by 1099.53% to $819065.0 in 2025.
  • Its EBITDA stands at $819065.0 for Q3 2025, versus $913999.0 for Q2 2025 and $501639.0 for Q1 2025.